NCSP: 3Cs and HIV programme

The programme aims to improve staffs' awareness and skills to increase opportunistic offers of chlamydia testing, provision of contraceptive service information and free condoms (the 3Cs) to 15 to 24 year olds and HIV testing.

GP engagement pilot

The National Chlamydia Screening Programme (NCSP) is committed to opportunistic chlamydia screening for young adults, delivered as part of a basic sexual health offer in routine primary care and sexual health consultations. We recognise the valuable contribution that general practice can and does make to this work. We also recognise that practice varies. To support general practices and local areas increase screening, PHE piloted the 3Cs & HIV programme during 2013 to 2015.

The 3Cs & HIV pilot focuses on supporting practices across England to:

  • provide the ‘3Cs’ offer of a chlamydia screen, signposting or provision of contraceptive advice and free condoms, during routine consultations with young adults (15 to 24 year olds)
  • deliver HIV testing in adults (>= 16 years) in line with current clinical guidelines: raising awareness of indicator conditions where HIV testing should be considered and, in high prevalence areas, routine offer of HIV test to all new practice registrants

The 3Cs & HIV pilot was designed to strengthen sexual health work already funded and underway in local areas, being delivered by general practices. The pilot’s design and evaluation was informed and guided by a GP and practice nurse advisory panel.

The programme adapts an intervention previously trialled by PHE, based on the Theory of Planned Behaviour. In this randomised controlled trial, surgeries that fully engaged with the pilot intervention increased chlamydia detection by 76% (p=0.005). The trial results provide a realistic measure of the likely take-up and efficacy of the 3Cs & HIV programme, when commissioned in general practice.

For more information on the 3Cs & HIV pilot design and evaluation methodology please see the protocol paper.

Pilot results

The 3Cs & HIV results are currently being analysed.